Munich \u2014 FSN Capi\u00adtal, a private equity firm with offices in Scan\u00addi\u00adna\u00advia and Germany, has successfully comple\u00adted fund\u00adrai\u00adsing for a new special fund. Insti\u00adtu\u00adtio\u00adnal inves\u00adtors have pled\u00adged more than EUR 400 million for invest\u00adments in parti\u00adcu\u00adlarly ESG-orien\u00adted SMEs. This excee\u00added the origi\u00adnal target set for the new Compass Fund. The capi\u00adtal commit\u00adments come from well-known insti\u00adtu\u00adtio\u00adnal inves\u00adtors such as foun\u00adda\u00adti\u00adons, pension funds and insu\u00adrance compa\u00adnies as well as private inves\u00adtors; more than half of the funds come from North America and around 30 percent from Scan\u00addi\u00adna\u00advia and the DACH region.<\/p>\n
Respon\u00adsi\u00adble invest\u00adment approach Epista Life Science alre\u00adady in the portfolio Support in achie\u00adving ESG goals Accor\u00adding to Rebecca Svens\u00f8y, Head of ESG at FSN Capi\u00adtal<\/strong>The Compass Fund uses an indus\u00adtry-leading ESG approach, ther\u00adeby conso\u00adli\u00adda\u00adting FSN Capi\u00adtal\u2019s posi\u00adtion as a parti\u00adcu\u00adlarly respon\u00adsi\u00adble private equity company: \u201cFor us, ESG is not just about risk mini\u00admiza\u00adtion and report\u00ading compli\u00adance \u2014 in addi\u00adtion to value crea\u00adtion, we are prima\u00adrily concer\u00adned with the full deve\u00adlo\u00adp\u00adment of exci\u00adting, sustainable poten\u00adtial. We actively support compa\u00adnies in imple\u00admen\u00adting their ESG goals.\u201d<\/p>\n About FSN Capital Munich \u2014 FSN Capi\u00adtal, a private equity firm with offices in Scan\u00addi\u00adna\u00advia and Germany, has successfully comple\u00adted fund\u00adrai\u00adsing for a new special fund. Insti\u00adtu\u00adtio\u00adnal inves\u00adtors have pled\u00adged more than EUR 400 million for invest\u00adments in parti\u00adcu\u00adlarly ESG-orien\u00ad\u00adted SMEs. This excee\u00added the origi\u00adnal target set for the new Compass Fund. The capi\u00adtal commit\u00adments come from well-known [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":51436,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1368,1369,1372],"tags":[],"class_list":["post-51438","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-consultants-auditors","category-investors","category-consultant"],"yoast_head":"\n
\n<\/strong>
\nRobin M\u00fcrer, Co-Mana\u00adging Part\u00adner at FSN Capi\u00adtal<\/strong> in Munich, says: \u201cThe addi\u00adtio\u00adnal small-cap focus comple\u00adments our exis\u00adting mid-cap stra\u00adtegy. The FSN funds have inves\u00adted in eight compa\u00adnies in the DACH region over the past seven years and we have found that our respon\u00adsi\u00adble invest\u00adment approach has been very well recei\u00adved in our second home market \u2014 in this respect, the Compass Fund is a logi\u00adcal exten\u00adsion of our previous invest\u00adment acti\u00advi\u00adties. It enables exci\u00adting growth part\u00adner\u00adships with smal\u00adler, soci\u00adally commit\u00adted compa\u00adnies for which our value crea\u00adtion model and ESG focus are attrac\u00adtive. And we see this in Germany in parti\u00adcu\u00adlar, where sustaina\u00adbi\u00adlity is play\u00ading an incre\u00adasingly important role in busi\u00adness and society.\u201d<\/p>\n
\n<\/strong>
\nThe Compass Fund has alre\u00adady made its first invest\u00adments, inclu\u00adding in the company Epista Life Science. The signi\u00adfi\u00adcantly growing IT service and consul\u00adting company for the biopharma indus\u00adtry has 150 employees in Germany, Switz\u00ader\u00adland, Sweden and Denmark who support life science compa\u00adnies world\u00adwide with digi\u00adta\u00adliza\u00adtion, compli\u00adance and quality assu\u00adrance. A parti\u00adcu\u00adlar focus is the imple\u00admen\u00adta\u00adtion of inno\u00adva\u00adtive proces\u00adses and tech\u00adno\u00adlo\u00adgies that enable custo\u00admers to successfully adapt to new regu\u00adla\u00adtory requi\u00adre\u00adments and at the same time drive inno\u00adva\u00adtion in the health\u00adcare sector. With this inter\u00adface between busi\u00adness, poli\u00adtics and society, the invest\u00adment is a prime exam\u00adple of the Compass Fund\u2019s invest\u00adment approach.<\/p>\n
\n<\/strong>
\nFSN Capi\u00adtal has alre\u00adady laun\u00adched six funds for invest\u00adments in larger medium-sized compa\u00adnies over the past 25 years; over EUR 1.8 billion was raised for the last fund FSN Capi\u00adtal VI in 2021. The Compass Fund, with its focus on SMEs that address the major social chal\u00adlenges of the coming decade with their products and services, builds on the previous stra\u00adtegy and is mana\u00adged by the same team with proven proces\u00adses and strategies.<\/p>\n
\n<\/strong>
\nFSN Capi\u00adtal, one of the leading Nort\u00adhern Euro\u00adpean private equity firms, was foun\u00added in 1999 and has four offices in Oslo, Stock\u00adholm, Copen\u00adha\u00adgen and since 2017 also in Munich The four funds advi\u00adsed by FSN Capi\u00adtal have four billion euros under manage\u00adment; for the latest Fund VI, 1.8 billion euros were raised for invest\u00adments in Scan\u00addi\u00adna\u00advia and the DACH region The funds make majo\u00adrity invest\u00adments in growth-orien\u00adted compa\u00adnies in order to support them on their further path to success and to make them even more sustainable, compe\u00adti\u00adtive, inter\u00adna\u00adtio\u00adna\u00adli\u00adzed and profi\u00adta\u00adble. FSN Capi\u00adtal\u2019s 97-strong team (29 of whom are based in Munich) is commit\u00adted to inves\u00adt\u00ading respon\u00adsi\u00adbly, achie\u00adving a posi\u00adtive ESG impact on the port\u00adfo\u00adlio and deli\u00adve\u00adring market-leading returns, true to the motto \u201cWe are decent people making a decent return in a decent way\u201d. The current port\u00adfo\u00adlio compa\u00adnies in Germany include B\u00e4cker G\u00f6rtz, MEGABAD (Swash Group), Ecovium, Lobs\u00adter, impreg, Adra\u00adgos Pharma, Rame\u00adder and TASKING.
\nFor more infor\u00adma\u00adtion, visit www.fsncapital.com.<\/p>\n","protected":false},"excerpt":{"rendered":"